SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+8.17%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$288M
AUM Growth
+$288M
(-1.7%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
83
New
8
Increased
26
Reduced
32
Closed
13
Top Buys
| 1 |
Cigna
CI
|
$9.72M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$5.03M |
| 3 |
STJ
St Jude Medical
STJ
|
$3.45M |
| 4 |
Centene
CNC
|
$3.18M |
| 5 |
Community Health Systems
CYH
|
$3.09M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$5.91M |
| 2 |
UnitedHealth
UNH
|
$4.73M |
| 3 |
Cencora
COR
|
$4.36M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.23M |
| 5 |
Amgen
AMGN
|
$3.2M |
Sector Composition
| 1 | Healthcare | 83.66% |
| 2 | Financials | 3.08% |
| 3 | Energy | 1.06% |
| 4 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRX
51
DELISTED
Akorn, Inc.
AKRX
| $2.18M | 0.76% |
50,000
+20,000
| +67% | +$873K |
|
52
Quest Diagnostics
DGX
$20.3B
| $2.18M | 0.76% |
30,000
-40,000
| -57% | -$2.9M |
|
53
Vertex Pharmaceuticals
VRTX
$100B
| $2.1M | 0.73% |
+17,000
| New | +$2.1M |
|
54
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.09M | 0.73% |
50,000
+15,000
| +43% | +$628K |
|
|
HSP
55
DELISTED
HOSPIRA INC
HSP
| $2.07M | 0.72% |
23,300
-3,000
| -11% | -$266K |
|
|
HRC
56
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.07M | 0.72% |
38,020
-10,000
| -21% | -$543K |
|
|
GEN
57
DELISTED
Genesis Healthcare, Inc.
GEN
| $2.03M | 0.7% |
307,580
-92,420
| -23% | -$610K |
|
|
TRNX
58
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2M | 0.69% |
80,000
-50,000
| -38% | -$1.25M |
|
59
Molina Healthcare
MOH
$9.8B
| $1.93M | 0.67% |
27,500
-22,600
| -45% | -$1.59M |
|
|
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.37M | 0.47% |
30,000
+5,000
| +20% | +$228K |
|
61
Esperion Therapeutics
ESPR
$448M
| $1.23M | 0.43% |
+15,000
| New | +$1.23M |
|
62
PTC Therapeutics
PTCT
$3.92B
| $1.2M | 0.42% |
+25,000
| New | +$1.2M |
|
|
JUNO
63
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.07M | 0.37% |
20,000
| – | – |
|
|
BLUE
64
DELISTED
bluebird bio
BLUE
| $1.01M | 0.35% |
6,000
-3,000
| -33% | -$505K |
|
|
ANAC
65
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.01M | 0.35% |
+13,000
| New | +$1.01M |
|
66
Cardinal Health
CAH
$35.5B
| $962K | 0.33% |
11,500
-38,000
| -77% | -$3.18M |
|
|
67
Cencora
COR
$56.5B
| $957K | 0.33% |
9,000
-41,000
| -82% | -$4.36M |
|
|
SAGE
68
DELISTED
Sage Therapeutics
SAGE
| $949K | 0.33% |
+13,000
| New | +$949K |
|
69
Cross Country Healthcare
CCRN
$438M
| $863K | 0.3% |
68,028
-96,972
| -59% | -$1.23M |
|
70
Agilent Technologies
A
$35.7B
| – | – |
-70,000
| Closed | -$2.91M |
|
71
Abbott
ABT
$231B
| – | – |
-50,000
| Closed | -$2.32M |
|
72
Align Technology
ALGN
$10.3B
| – | – |
-35,000
| Closed | -$1.88M |
|
|
73
Amgen
AMGN
$155B
| – | – |
-20,000
| Closed | -$3.2M |
|
74
Avanos Medical
AVNS
$554M
| – | – |
-50,000
| Closed | -$2.46M |
|
75
Ironwood Pharmaceuticals
IRWD
$214M
| – | – |
-75,000
| Closed | -$1.2M |
|